Medicus Pharma (MDCX) Other Non Operating Income (2024 - 2026)
Medicus Pharma's (MDCX) quarterly Other Non Operating Income came in at -$21558.0 in Q4 2025, up 96.12% on a QoQ basis from -$554972.0 in Q3 2025.
Medicus Pharma (MDCX) Other Non Operating Income (2024 - 2026) Analysis & Trends
Medicus Pharma (MDCX) has 2 years of Other Non Operating Income data on file, last reported at -$21558.0 in Q4 2025.
- Quarterly Other Non Operating Income changed N/A year-over-year to -$21558.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$712660.0 (down 2931.18% YoY) and the FY2025 annual result came in at -$10730.0, changed N/A from the prior year.
- Other Non Operating Income grew to -$21558.0 in Q4 2025, from -$554972.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $55514.0 in Q3 2024 to a low of -$554972.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -205,638.00 |
| Dec 31, 2025 | -21,558.00 |
| Sep 30, 2025 | -554,972.00 |
| Jun 30, 2025 | -159,996.00 |
| Mar 31, 2025 | 23,866.00 |
| Sep 30, 2024 | 55,514.00 |
| Jun 30, 2024 | -79,025.00 |